OverviewSuggest Edit

Nuritas is a company revolutionizing the discovery of novel and natural active ingredients with scientifically proven health benefits. Our disruptive approach to discovery combines artificial intelligence and DNA analysis to data-mine billions of molecules. This means that for the first time Nuritas can rapidly and efficiently provide access to the most health-benefiting components within foods, called bioactive peptides. Our life-changing peptides, the subject of pending patent applications, provide unique solutions for the maintenance of health and wellness. These benefits include: anti-inflammatory activity, antimicrobial activity, muscle recovery enhancement, skin anti-aging solutions, and the potential management of blood sugar levels for type 2 diabetics. Put in a nutshell, the company discovers and unlocks ingredients from food sources in a completely unique way, providing natural, sustainable and scientifically proven health solutions. Our dynamic peptides have a vast range of applications in multiple industries including functional and medical foods, pharmaceuticals, dietary supplements, and cosmetics and personal care.
HQDublin 2, IE

Latest Updates

Employees (est.) (Apr 2022)47(+5%)
Cybersecurity ratingCMore
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background

Key People/Management at Nuritas

Emmet Browne

Emmet Browne

Tim Considine

Tim Considine

Chief Strategy Officer
Arthur Hiller

Arthur Hiller

Chief Corporate Development Officer
Show more

Nuritas Office Locations

Nuritas has offices in Dublin 2 and Cambridge
Dublin 2, IE (HQ)
14th floor, Joshua Dawson House, Dawson St
Cambridge, MA, US
One Broadway, 1 Broadway 14th floor
Show all (2)

Nuritas Financials and Metrics

Summary Metrics

Founding Date


Nuritas total Funding

$27.4 m

Nuritas latest funding size

$18.9 m

Time since last funding

4 years ago

Nuritas investors

Nuritas's latest funding round in December 2017 was reported to be $18.9 m. In total, Nuritas has raised $27.4 m
Show all financial metrics

Nuritas Cybersecurity Score

Cybersecurity ratingPremium dataset



SecurityScorecard logo

Nuritas Online and Social Media Presence

Embed Graph

Nuritas News and Updates

Dutch biotech company Nuritas lands $20 mln Series A

Dublin-based biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Irish biotech company Nuritas lands $20 mln Series A

Irish biotech company Nuritas has raised $20 million in Series A funding. Cultivian Sandbox Ventures led the round.

Biotech startup Nuritas raises €16 million in Series A funding

Nuritas, an Irish biotech startup, has raised €16 million in a Series A round led by US firm Cultivian Sandbox Ventures. Nuritas has built a medical platform that uses artificial intelligence to analyse peptides in food, which it claims is 500 times faster than current technology. “Our artificial in…

Nuritas Blogs

Nuritas™ Announces North American Headquarters, CEO to Relocate to US

Biotech company sharing first details for its commercial and scientific base in Connecticut during the Yale Innovation Summit DUBLIN, May 17, 2022 – Nuritas, a biotechnology company using AI to...

Dr Nora Khaldi shares leadership insights with Authority Magazine

Our founder & CEO Dr Nora Khaldi was profiled for Authority Magazine’s Women of the C-suite series, read the full interview to glean some insights on Nora’s leadership and vision.

Nuritas featured in Nutrition Insight

Nuritas communications scientific lead, Dr. Audrey Wall, speaks to Nutrition Insight about the unparalleled opportunity in peptides and how AI is driving innovation. https://www.nutritioninsight.com/news/unparalleled-opportunity-in-peptides-nuritas-ceo-reveals-as-ai-drives-supplement-innovation.html

Nuritas presents at International Conference on Frailty and Sarcopenia Research

Nuritas team members Dr Rob Radford and Dr Brian Keogh presented our latest muscle and sarcopenia data at the ICFSR.    

Dr Nora Khaldi in Nutrition Business Journal

Our founder & CEO Dr. Nora K. spoke with Nutrition Business Journal on how AI is discovering natural ingredients for food, supplements and beyond from food and plant sources. https://www.newhope.com/ingredients/artificial-intelligence-discovers-ingredients-food-supplements  

Nuritas featured in VisVires New Protein Investor Conference

We had the pleasure of being highlighted as one of the VVNP portfolio companies of choice in their recent investor conference.
Show more

Nuritas Frequently Asked Questions

  • When was Nuritas founded?

    Nuritas was founded in 2014.

  • Who are Nuritas key executives?

    Nuritas's key executives are Emmet Browne, Tim Considine and Arthur Hiller.

  • How many employees does Nuritas have?

    Nuritas has 47 employees.

  • Who are Nuritas competitors?

    Competitors of Nuritas include Terray Therapeutics, Causaly and Elucidata.

  • Where is Nuritas headquarters?

    Nuritas headquarters is located at 14th floor, Joshua Dawson House, Dawson St, Dublin 2.

  • Where are Nuritas offices?

    Nuritas has offices in Dublin 2 and Cambridge.

  • How many offices does Nuritas have?

    Nuritas has 2 offices.